Anika Therapeutics | ANIK - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
Abbott USD 5.94B 642M 2026-06
Agenus USD 642K 399K 2025-09
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Anika Therapeutics USD 11.44M 797K 2025-12
Halozyme Therapeutics USD 108.68M 67K 2026-06
Heron Therapeutics USD 11.12M 795K 2025-12
Insmed USD 69.29M 19.79M 2026-06
Integra LifeSciences USD 188.86M 10.15M 2026-06
Intrexon USD 1.01M 344K 2024-06
J&J USD 8.08B 80M 2026-09
Karyopharm Therapeutics USD 1.34M 139K 2026-03
Ligand Pharmaceuticals USD 11.31M 59K 2026-06
MacroGenics USD 9.53M 585K 2026-03
Merit Medical Systems USD 203.68M 6.6M 2026-06
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
Sanofi EUR 3.02B 656M 2026-06
Smith & Nephew USD 901M 31M 2026-06
Stryker USD 2.26B 106M 2026-06
Veracyte USD 42.19M 3.7M 2026-06
Xencor USD 61.66M 50.95M 2025-06
Zimmer Biomet Holdings USD 815.9M 77.6M 2026-06